vs
Side-by-side financial comparison of Avantor, Inc. (AVTR) and 10x Genomics, Inc. (TXG). Click either name above to swap in a different company.
Avantor, Inc. is an American biotechnology, chemicals, and pharmaceutical company headquartered in Radnor, Pennsylvania. Established in 1904 as J.T. Baker, the company changed its name to Avantor in 2010. Avantor went public in 2019 and is now listed on the New York Stock Exchange under the symbol “AVTR”.
10x Genomics, Inc. is an American biotechnology company that designs and manufactures gene sequencing technology used in scientific research. It was founded in 2012 by Serge Saxonov, Ben Hindson, and Kevin Ness.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.7B | — | ||
| Q3 25 | $1.6B | — | ||
| Q2 25 | $1.7B | — | ||
| Q1 25 | $1.6B | — | ||
| Q4 24 | $1.7B | — | ||
| Q3 24 | $1.7B | — | ||
| Q2 24 | $1.7B | — | ||
| Q1 24 | $1.7B | — |
| Q4 25 | $52.4M | — | ||
| Q3 25 | $-711.8M | — | ||
| Q2 25 | $64.7M | — | ||
| Q1 25 | $64.5M | — | ||
| Q4 24 | $500.4M | — | ||
| Q3 24 | $57.8M | — | ||
| Q2 24 | $92.9M | — | ||
| Q1 24 | $60.4M | — |
| Q4 25 | 31.5% | — | ||
| Q3 25 | 32.4% | — | ||
| Q2 25 | 32.9% | — | ||
| Q1 25 | 33.8% | — | ||
| Q4 24 | 33.4% | — | ||
| Q3 24 | 32.9% | — | ||
| Q2 24 | 34.1% | — | ||
| Q1 24 | 34.0% | — |
| Q4 25 | 7.6% | — | ||
| Q3 25 | -40.0% | — | ||
| Q2 25 | 7.7% | — | ||
| Q1 25 | 9.3% | — | ||
| Q4 24 | 37.8% | — | ||
| Q3 24 | 7.3% | — | ||
| Q2 24 | 10.3% | — | ||
| Q1 24 | 8.7% | — |
| Q4 25 | 3.1% | — | ||
| Q3 25 | -43.8% | — | ||
| Q2 25 | 3.8% | — | ||
| Q1 25 | 4.1% | — | ||
| Q4 24 | 29.7% | — | ||
| Q3 24 | 3.4% | — | ||
| Q2 24 | 5.5% | — | ||
| Q1 24 | 3.6% | — |
| Q4 25 | $0.08 | — | ||
| Q3 25 | $-1.04 | — | ||
| Q2 25 | $0.09 | — | ||
| Q1 25 | $0.09 | — | ||
| Q4 24 | $0.73 | — | ||
| Q3 24 | $0.08 | — | ||
| Q2 24 | $0.14 | — | ||
| Q1 24 | $0.09 | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
